<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK51671" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK51671/" /><meta name="ncbi_pagename" content="Epimerase Deficiency Galactosemia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Epimerase Deficiency Galactosemia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Epimerase Deficiency Galactosemia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/06/16" /><meta name="citation_author" content="Judith Fridovich-Keil" /><meta name="citation_author" content="Lora Bean" /><meta name="citation_author" content="Miao He" /><meta name="citation_author" content="Richard Schroer" /><meta name="citation_pmid" content="21290786" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK51671/" /><meta name="citation_keywords" content="GALE Deficiency" /><meta name="citation_keywords" content="Galactosemia Type III" /><meta name="citation_keywords" content="UDP-Galactose-4'-Epimerase Deficiency" /><meta name="citation_keywords" content="GALE Deficiency" /><meta name="citation_keywords" content="Galactosemia Type III" /><meta name="citation_keywords" content="UDP-glucose 4-epimerase" /><meta name="citation_keywords" content="GALE" /><meta name="citation_keywords" content="Epimerase Deficiency Galactosemia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Epimerase Deficiency Galactosemia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Judith Fridovich-Keil" /><meta name="DC.Contributor" content="Lora Bean" /><meta name="DC.Contributor" content="Miao He" /><meta name="DC.Contributor" content="Richard Schroer" /><meta name="DC.Date" content="2016/06/16" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK51671/" /><meta name="description" content="Epimerase deficiency galactosemia (GALE deficiency galactosemia) is a continuum comprising three forms:" /><meta name="og:title" content="Epimerase Deficiency Galactosemia" /><meta name="og:type" content="book" /><meta name="og:description" content="Epimerase deficiency galactosemia (GALE deficiency galactosemia) is a continuum comprising three forms:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK51671/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gale-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK51671/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88821EDFC890F10000000003070177.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK51671_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK51671_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/eb-pa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ea1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK51671_"><span class="title" itemprop="name">Epimerase Deficiency Galactosemia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: GALE Deficiency, Galactosemia Type III, UDP-Galactose-4'-Epimerase Deficiency</div><p class="contrib-group"><span itemprop="author">Judith Fridovich-Keil</span>, PhD, <span itemprop="author">Lora Bean</span>, PhD, <span itemprop="author">Miao He</span>, PhD, and <span itemprop="author">Richard Schroer</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK51671_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK51671_ai__"><div class="contrib half_rhythm"><span itemprop="author">Judith Fridovich-Keil</span>, PhD<div class="affiliation small">Department of Human Genetics<br />Emory University School of Medicine<br />Atlanta, Georgia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.yrome@vodirfj" class="oemail">ude.yrome@vodirfj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lora Bean</span>, PhD<div class="affiliation small">Division of Medical Genetics<br />Department of Human Genetics<br />Emory University School of Medicine<br />Atlanta, Georgia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.yrome@naebjl" class="oemail">ude.yrome@naebjl</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Miao He</span>, PhD<div class="affiliation small">Department of Pathology and Laboratory Medicine<br />University of Pennsylvania<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@meh" class="oemail">ude.pohc.liame@meh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Richard Schroer</span>, MD<div class="affiliation small">Greenwood Genetic Center<br />Greenwood, South Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cgg@reorhcs" class="oemail">gro.cgg@reorhcs</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 25, 2011</span>; Last Update: <span itemprop="dateModified">June 16, 2016</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gale-def.Summary" itemprop="description"><h2 id="_gale-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Epimerase deficiency galactosemia (GALE deficiency galactosemia) is a continuum comprising three forms:</p><ul><li class="half_rhythm"><div>Generalized. Enzyme activity is profoundly decreased in all tissues tested.</div></li><li class="half_rhythm"><div>Peripheral. Enzyme activity is deficient in red blood cells (RBC) and circulating white blood cells, but normal or near normal in all other tissues.</div></li><li class="half_rhythm"><div>Intermediate. Enzyme activity is deficient in red blood cells and circulating white blood cells and less than 50% of normal levels in other cells tested.</div></li></ul><p>Infants with generalized epimerase deficiency galactosemia develop clinical findings on a regular milk diet (which contains lactose, a disaccharide of galactose and glucose); manifestations include hypotonia, poor feeding, vomiting, weight loss, jaundice, hepatomegaly, liver dysfunction, aminoaciduria, and cataracts. Prompt removal of galactose/lactose from their diet resolves or prevents these acute symptoms. In contrast, neonates with the peripheral or intermediate form generally remain clinically well even on a regular milk diet and are usually only identified by biochemical testing, often in <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of epimerase deficiency galactosemia is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with impaired GALE activity in RBC and/or the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GALE</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The degree of GALE enzyme activity impairment in RBC does not distinguish between the clinically severe generalized and the milder intermediate or peripheral forms of epimerase deficiency. Further testing in other cell types such as stimulated leukocytes or EBV-transformed lymphoblasts is required to make that distinction.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> The acute and potentially lethal symptoms of generalized epimerase deficiency galactosemia are prevented or corrected by a galactose/lactose-restricted diet. Note: Affected individuals may require trace environmental sources of galactose: infants should be fed a formula (e.g., soy formula) that contains trace levels of galactose or lactose. Continued dietary restriction of dairy products in older children is recommended. In contrast, infants with peripheral epimerase deficiency galactosemia are believed to remain asymptomatic regardless of diet; infants with intermediate epimerase deficiency galactosemia may benefit in the long term from early dietary galactose/lactose restriction, but this remains unclear.</p><p><i>Prevention of primary manifestations:</i> In generalized epimerase deficiency galactosemia, restriction of dietary galactose/lactose appears to correct or prevent the acute signs and symptoms of the disorder (hepatic dysfunction, renal dysfunction, and mild cataracts), but not the developmental delay or learning impairment observed in some children. Because of the difficulty in distinguishing peripheral and intermediate forms of epimerase deficiency galactosemia, dietary restriction of galactose/lactose is recommended for all infants with GALE deficiency, relaxing the restriction as warranted once a more accurate diagnosis has been confirmed.</p><p><i>Surveillance:</i> Hemolysate gal-1P (galactose-1-phosphate) or urinary galactitol is monitored, especially if the diet is to be normalized. Acceptable levels of RBC gal-1P are not known, but are estimated to be &#x0003c;3.5 mg/100 mL (normal &#x02264;1.0 mg/100 mL) on data from classic galactosemia. Other parameters that warrant monitoring are growth and developmental milestones.</p><p><i>Agents/circumstances to avoid:</i> Dietary galactose/lactose in persons with generalized epimerase deficiency galactosemia, certainly as infants and perhaps for life.</p><p><i>Evaluation of relatives at risk:</i> Each at-risk newborn sib should be treated from birth while awaiting results of diagnostic testing for epimerase deficiency galactosemia; either <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (if the pathogenic variants in the family are known) or measurement of GALE enzyme activity in RBC (if the pathogenic variants in the family are not known) can be performed.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Epimerase deficiency galactosemia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each full sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="gale-def.Diagnosis"><h2 id="_gale-def_Diagnosis_">Diagnosis</h2><p>Epimerase deficiency galactosemia (GALE deficiency galactosemia) is a continuum comprising three forms:</p><ul><li class="half_rhythm"><div>Generalized. Enzyme activity is profoundly decreased in all tissues tested.</div></li><li class="half_rhythm"><div>Peripheral. Enzyme activity is deficient in red blood cells (RBC) and circulating white blood cells, but normal or near normal in all other tissues.</div></li><li class="half_rhythm"><div>Intermediate. Enzyme activity is deficient in RBC and circulating white blood cells and less than 50% of normal levels in other cells tested.</div></li></ul><div id="gale-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Epimerase deficiency galactosemia <b>should be suspected</b> in individuals (on a normal milk diet) with the following <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> results, clinical features, and supportive laboratory findings:</p><p><b>Newborn screening results</b></p><ul><li class="half_rhythm"><div>In states in which the <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> program includes measurements of both total galactose (gal+gal-1P) and GALT enzyme activity (see <a href="/books/n/gene/galactosemia/">Galactosemia</a>):</div><ul><li class="half_rhythm"><div>Total galactose (sum of galactose and galactose-1-phosphate) is elevated; and</div></li><li class="half_rhythm"><div>GALT enzyme activity is normal.</div></li></ul></li><li class="half_rhythm"><div>In states in which total galactose is only measured if GALT enzyme activity is low, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant will have a normal <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> result for galactosemia.</div></li></ul><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Poor feeding</div></li><li class="half_rhythm"><div>Vomiting</div></li><li class="half_rhythm"><div>Weight loss</div></li><li class="half_rhythm"><div>Jaundice</div></li><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Liver dysfunction</div></li><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>No clinical findings (peripheral and intermediate forms)</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Elevated RBC hemolysate gal-1P concentration (normal 0-1.0 mg/100 mL RBC):</div><ul><li class="half_rhythm"><div>As high as 170 mg/100 mL packed RBC in those with generalized epimerase deficiency</div></li><li class="half_rhythm"><div>&#x0003e;30 mg/100 mL packed RBC in those with intermediate or peripheral epimerase deficiency</div></li></ul></li><li class="half_rhythm"><div>Urinary galactose concentrations as high as 116 mmol/L (2.09 g/100 mL, control &#x0003c;30 mg/100 mL)</div></li><li class="half_rhythm"><div>Non-glucose reducing substance in the urine (which represents urinary galactose)</div></li><li class="half_rhythm"><div>Elevated urinary galactitol concentrations (normal &#x0003c;94.7 mmol/mol creatinine for age &#x0003c;1 year, &#x0003c;45.3 mmol/mol creatinine for age 1-6 years, &#x0003c;18.4 mmol/mol creatinine for age &#x0003e;6 years)</div></li><li class="half_rhythm"><div>Generalized aminoaciduria</div></li><li class="half_rhythm"><div>Normal GALT enzyme activity</div></li></ul></div><div id="gale-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>A diagnosis of epimerase deficiency galactosemia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by one or more of the following:</p><ul><li class="half_rhythm"><div>0.0-8.0 &#x003bc;mol/hr/g hemoglobin (Hb) GALE enzyme activity in red blood cells (RBC) (normal 17.1-40.1 &#x003bc;mol/hr/g Hb) as determined by the traditional spectrophotometric assay</div></li><li class="half_rhythm"><div>&#x0003c;0.5 &#x003bc;mol/hr/g Hb GALE enzyme activity in RBC using liquid chromatography/tandem mass spectrometry (normal 2.3-12.7 &#x003bc;mol/hr/g Hb) [<a class="bk_pop" href="#gale-def.REF.chen.2014.5">Chen et al 2014</a>]</div></li><li class="half_rhythm"><div>The identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GALE</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK51671/table/gale-def.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figgaledefTmoleculargenetictestinguse" rid-ob="figobgaledefTmoleculargenetictestinguse">Table 1</a>)</div></li></ul><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GALE</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GALE</i> and other genes of interest (see <a href="#gale-def.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="gale-def.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Epimerase Deficiency Galactosemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK51671/table/gale-def.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gale-def.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALE</i></td><td headers="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/16 alleles and 13/14 alleles (~90%)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_gale-def.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gale-def.TF.1.1"><p class="no_margin">See <a href="/books/NBK51671/#gale-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="gale-def.TF.1.2"><p class="no_margin">See <a href="#gale-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="gale-def.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="gale-def.TF.1.4"><p class="no_margin">Whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing has revealed ostensibly causal <i>GALE</i> variants in most persons with biochemically confirmed GALE deficiency who have been studied (e.g., <a class="bk_pop" href="#gale-def.REF.park.2005.646">Park et al [2005]</a>, <a class="bk_pop" href="#gale-def.REF.openo.2006.89">Openo et al [2006]</a>, reviewed in <a class="bk_pop" href="#gale-def.REF.fridovichkeil.2008">Fridovich-Keil &#x00026; Walter [2008]</a>); however due to the small number of alleles studied and the biochemical complexity of the diagnosis this estimate may change with time.</p></div></dd><dt>5. </dt><dd><div id="gale-def.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="gale-def.TF.1.6"><p class="no_margin">No deletions or duplications involving <i>GALE</i> have been reported to cause epimerase deficiency galactosemia.</p></div></dd></dl></div></div></div><div id="gale-def.Additional_Testing"><h4>Additional Testing</h4><p>GALE enzyme activity can be measured in fibroblasts or lymphoblasts to help distinguish between the generalized, peripheral, and intermediate forms of epimerase deficiency galactosemia; however, to the authors&#x02019; knowledge this testing is not currently offered on a clinical basis.</p></div></div></div><div id="gale-def.Clinical_Characteristics"><h2 id="_gale-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="gale-def.Clinical_Description"><h3>Clinical Description</h3><p>The clinical severity of epimerase deficiency galactosemia caused by reduced activity of the enzyme GALE [<a class="bk_pop" href="#gale-def.REF.fridovichkeil.2008">Fridovich-Keil &#x00026; Walter 2008</a>] ranges from potentially lethal [<a class="bk_pop" href="#gale-def.REF.holton.1981.885">Holton et al 1981</a>, <a class="bk_pop" href="#gale-def.REF.henderson.1983.17">Henderson et al 1983</a>, <a class="bk_pop" href="#gale-def.REF.walter.1999.374">Walter et al 1999</a>, <a class="bk_pop" href="#gale-def.REF.sarkar.2010.909">Sarkar et al 2010</a>] to apparently benign [<a class="bk_pop" href="#gale-def.REF.gitzelmann.1972.125">Gitzelmann 1972</a>].</p><p>Epimerase deficiency galactosemia can be divided by apparent enzyme activity level into the following three forms: generalized, peripheral, and intermediate (see <a href="#gale-def.Diagnosis">Diagnosis</a>) [<a class="bk_pop" href="#gale-def.REF.openo.2006.89">Openo et al 2006</a>]. Note: In all three forms GALE enzyme activity is deficient in peripheral circulating red and white blood cells.</p><p>A key difference between generalized epimerase deficiency galactosemia and intermediate or peripheral epimerase deficiency galactosemia is that individuals with generalized epimerase deficiency galactosemia develop clinical findings on a normal milk diet while infants with peripheral or intermediate epimerase deficiency galactosemia remain clinically well, at least in the neonatal period.</p><div id="gale-def.Generalized_Epimerase_Deficienc"><h4>Generalized Epimerase Deficiency Galactosemia</h4><p>Infants with generalized epimerase deficiency galactosemia who are on a diet containing galactose/lactose typically present with symptoms reminiscent of <a href="/books/n/gene/galactosemia/">classic galactosemia</a>: hypotonia, poor feeding, vomiting, weight loss, jaundice, hepatomegaly, liver dysfunction (e.g., markedly elevated serum transaminases), aminoaciduria, and cataracts. Prompt removal of galactose/lactose from the diet resolves or prevents these acute symptoms [<a class="bk_pop" href="#gale-def.REF.walter.1999.374">Walter et al 1999</a>, <a class="bk_pop" href="#gale-def.REF.sarkar.2010.909">Sarkar et al 2010</a>] (see <a href="#gale-def.Management">Management</a>).</p><p>Long-term outcome information for persons with generalized epimerase deficiency galactosemia is limited: fewer than ten persons with this form have been reported [<a class="bk_pop" href="#gale-def.REF.walter.1999.374">Walter et al 1999</a>, <a class="bk_pop" href="#gale-def.REF.sarkar.2010.909">Sarkar et al 2010</a>]. Some have demonstrated long-term complications that became evident by early childhood (including sensorineural hearing impairment and physical and cognitive developmental delay and/or learning difficulties) while others have not. Of note, a majority of the individuals reported were born to <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents, raising the concern that homozygosity for other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> alleles, independent of <i>GALE</i>, may underlie some if not most of the long-term complications reported. Those few individuals with generalized epimerase deficiency who have been followed long-term demonstrate apparently normal puberty with no apparent evidence of premature ovarian insufficiency [<a class="bk_pop" href="#gale-def.REF.walter.1999.374">Walter et al 1999</a>].</p></div><div id="gale-def.Peripheral_Epimerase_Deficiency"><h4>Peripheral Epimerase Deficiency Galactosemia</h4><p>Neonates with the peripheral form are usually asymptomatic even on a regular milk diet; these infants are only identified following biochemical detection of elevated total galactose on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>.</p><p>Children with peripheral epimerase deficiency galactosemia appear to remain asymptomatic even if maintained on a normal milk diet.</p></div><div id="gale-def.Intermediate_Epimerase_Deficien"><h4>Intermediate Epimerase Deficiency Galactosemia</h4><p>Neonates with the intermediate form are also usually asymptomatic even on a regular milk diet and are only identified through <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>. The long-term outcome remains unclear. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual who was not treated with dietary restriction of galactose/lactose as an infant experienced delays in both motor and cognitive development that became evident by early childhood [<a class="bk_pop" href="#gale-def.REF.alano.1998.341">Alano et al 1998</a>, <a class="bk_pop" href="#gale-def.REF.openo.2006.89">Openo et al 2006</a>]. All other individuals known to have intermediate epimerase deficiency galactosemia have been treated by dietary galactose/lactose restriction, at least in infancy, and thus far those who have been followed appear to remain clinically well.</p></div><div id="gale-def.Pathophysiology"><h4>Pathophysiology</h4><p>Galactose is metabolized in humans and other species by the three-enzyme Leloir pathway comprising the enzymes galactokinase (GALK, EC 2.7.1.6), galactose 1-P uridylyltransferase (GALT, EC 2.7.7.12), and UDP-galactose 4'-epimerase (GALE, EC 5.1.3.2). As illustrated in <a class="figpopup" href="/books/NBK51671/figure/gale-def.F1/?report=objectonly" target="object" rid-figpopup="figgaledefF1" rid-ob="figobgaledefF1">Figure 1</a>, GALE catalyzes an essential step in this pathway converting UDP-galactose to UDP-glucose. GALE is a reversible enzyme that also catalyzes the synthesis of UDP-galactose from UDP-glucose when other sources of UDP-galactose are limiting. Functioning outside of the Leloir pathway, GALE also interconverts UDP-N-acetyl galactosamine and UDP-N-acetylglucosamine. All four of these UDP-sugars are essential substrates for the biosynthesis of glycoproteins and glycolipids in humans.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figgaledefF1" co-legend-rid="figlgndgaledefF1"><a href="/books/NBK51671/figure/gale-def.F1/?report=objectonly" target="object" title="Figure 1 " class="img_link icnblk_img figpopup" rid-figpopup="figgaledefF1" rid-ob="figobgaledefF1"><img class="small-thumb" src="/books/NBK51671/bin/gale-def-Image001.gif" src-large="/books/NBK51671/bin/gale-def-Image001.jpg" alt="Figure 1 " /></a><div class="icnblk_cntnt" id="figlgndgaledefF1"><h4 id="gale-def.F1"><a href="/books/NBK51671/figure/gale-def.F1/?report=objectonly" target="object" rid-ob="figobgaledefF1">Figure 1 </a></h4><p class="float-caption no_bottom_margin">Leloir pathway </p></div></div><p>As in <a href="/books/n/gene/galactosemia/">classic galactosemia</a>, the cataracts associated with epimerase deficiency galactosemia are believed to be caused by galactitol accumulation in the ocular lens; it is possible, but not proven, that other acute findings may be caused by tissue accumulation of gal-1P (galactose-1-phosphate) or other metabolites.</p><p>Persons with epimerase deficiency galactosemia who are exposed to galactose demonstrate abnormal accumulation of UDP-galactose (UDP-gal). However, because GALE is required in humans for the endogenous biosynthesis of UDP-gal and also UDP-N-acetylgalactosamine (UDP-galNAc), at least part of the pathophysiology of epimerase deficiency galactosemia may result from inadequate production of these compounds, especially in utero, ostensibly leading to deficient or aberrant production of glycoproteins and glycolipids including cerebrosides.</p></div></div><div id="gale-def.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Because insufficient numbers of individuals with molecularly confirmed epimerase deficiency galactosemia have been followed clinically to identify <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations, studies of transformed lymphoblasts or other "non-peripheral" cell types are the only way to distinguish biochemically between the different forms of epimerase deficiency galactosemia [<a class="bk_pop" href="#gale-def.REF.mitchell.1975.5026">Mitchell et al 1975</a>, <a class="bk_pop" href="#gale-def.REF.openo.2006.89">Openo et al 2006</a>].</p></div><div id="gale-def.Nomenclature"><h3>Nomenclature</h3><p>Some authors refer to the different forms of galactosemia as type I, type II, and type III galactosemia, in which:</p><ul><li class="half_rhythm"><div>Type I galactosemia refers to <a href="/books/n/gene/galactosemia/">GALT deficiency</a></div></li><li class="half_rhythm"><div>Type II galactosemia refers to GALK deficiency</div></li><li class="half_rhythm"><div>Type III galactosemia refers to GALE deficiency (epimerase deficiency galactosemia)</div></li></ul></div><div id="gale-def.Prevalence"><h3>Prevalence</h3><p>True prevalence figures are unavailable at this time. Generalized epimerase deficiency galactosemia is very rare; however, epimerase deficiency galactosemia detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> may be as frequent as about 1:6,700 among African American infants and about 1:70,000 among American infants of European ancestry [<a class="bk_pop" href="#gale-def.REF.alano.1997.191a">Alano et al 1997</a>, <a class="bk_pop" href="#gale-def.REF.fridovichkeil.2008">Fridovich-Keil &#x00026; Walter 2008</a>].</p></div></div><div id="gale-def.Genetically_Related_Allelic_Dis"><h2 id="_gale-def_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>GALE</i>.</p></div><div id="gale-def.Differential_Diagnosis"><h2 id="_gale-def_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>GALT deficiency.</b> Galactosemia caused by deficiency of the enzyme galactose-1-phosphate uridylyltransferase (GALT) may be divided into three clinical/biochemical phenotypes: (1) classic galactosemia; (2) clinical variant galactosemia; and (3) Duarte (biochemical variant) galactosemia. This categorization is based on: residual erythrocyte GALT enzyme activity; the levels of galactose metabolites (e.g., erythrocyte galactose-1-phosphate and urine galactitol) that are observed both off and on a lactose-restricted diet; and, most importantly, the likelihood that the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual will develop acute and chronic long-term complications. Biallelic pathogenic variants in <i>GALT</i> are causative; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/galactosemia/"><b>Classic galactosemia</b></a> can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and <i>E. coli</i> sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. The vast majority of women with classic galactosemia manifest premature ovarian insufficiency (POI).</div></li><li class="half_rhythm"><div><a href="/books/n/gene/galactosemia/"><b>Clinical variant galactosemia</b></a> can result in life-threatening complications in untreated infants including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding. It can occur in individuals of any ancestry with low residual GALT enzyme activity, but is perhaps exemplified by the disease associated with the p.Ser135Leu <i>GALT</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that occurs at high frequency in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) as the hypergalactosemia is not as marked as in classic galactosemia. As in classic galactosemia, if a lactose-restricted diet is provided during the first days of life, the severe acute neonatal complications are usually prevented. Long-term outcomes among treated individuals with clinical variant galactosemia may also be milder.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/duarte-gal/"><b>Duarte variant galactosemia (biochemical variant galactosemia)</b></a><b>.</b> Persons with Duarte variant galactosemia who are fed breast milk or a lactose-containing formula are typically (though not always) asymptomatic, at least as infants.</div></li></ul><p><b>Galactokinase (GALK) deficiency</b> (OMIM <a href="http://omim.org/entry/230200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">230200</a>) should be considered in otherwise healthy individuals with cataracts, increased plasma concentration of galactose, and increased urinary excretion of galactitol. Affected individuals have normal GALT enzyme activity and do NOT accumulate gal-1P. The cataracts are caused by accumulation of the galactose metabolite, galactitol, in the lens. Galactitol is an impermeant alcohol which results in increased intracellular osmolality and swelling with loss of plasma membrane redox potential and consequent cell death. Detection of reduced GALK enzyme activity in hemolysates is diagnostic. Biallelic pathogenic variants in <i>GALK1</i> are causative [<a class="bk_pop" href="#gale-def.REF.kolosha.2000.447">Kolosha et al 2000</a>, <a class="bk_pop" href="#gale-def.REF.hunter.2001.77">Hunter et al 2001</a>]; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>. The prevalence of GALK deficiency in most populations is unknown; however, a recent study from Germany reported a prevalence of about 1:40,000, which is similar to the prevalence of classic galactosemia in the same population [<a class="bk_pop" href="#gale-def.REF.hennermann.2011.399">Hennermann et al 2011</a>]. In other populations the prevalence may be far lower.</p><p><b>Other</b>. A number of other rare conditions, including the following, can also lead to elevated galactose or galactose metabolites in the blood or urine of an infant consuming milk:</p><ul><li class="half_rhythm"><div>Portosystemic venous shunting</div></li><li class="half_rhythm"><div>Hepatic arteriovenous malformations</div></li><li class="half_rhythm"><div>Fanconi-Bickel syndrome (OMIM <a href="http://omim.org/entry/227810" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">227810</a>) due to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC2A2</i>. Individuals with this condition have hepatorenal glycogen accumulation, impaired utilization of glucose and galatose, and proximal tubular nephropathy.</div></li><li class="half_rhythm"><div>Congenital disorder of glycosylation type 1T (OMIM <a href="http://omim.org/entry/614921" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614921</a>) due to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PGM1</i> [<a class="bk_pop" href="#gale-def.REF.tegtmeyer.2014.533">Tegtmeyer et al 2014</a>]. Individuals with this condition can manifest mildly increased galactose-1-phosphate levels in RBC. They may have cleft palate/bifid uvula at birth, and can develop intermittent hypoglycemia, dilated cardiomyopathy, exercise intolerance with increased serum creatine kinase, and liver disease.</div></li></ul></div><div id="gale-def.Management"><h2 id="_gale-def_Management_">Management</h2><div id="gale-def.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with epimerase deficiency galactosemia the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Measurement of height, weight, and head circumference</div></li><li class="half_rhythm"><div>Nutrition and feeding assessments</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Liver function testing (serum AST, ALT, albumin, total protein, total and conjugated bilirubin, prothrombin time, and partial thromboplastin time)</div></li><li class="half_rhythm"><div>Ophthalmology consult to evaluate for cataracts</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist</div></li></ul></div><div id="gale-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="gale-def.Generalized_Epimerase_Deficienc_1"><h4>Generalized Epimerase Deficiency Galactosemia</h4><p>The acute and potentially lethal symptoms of generalized epimerase deficiency galactosemia are prevented or corrected by a galactose/lactose-restricted diet. This means switching infants from breast milk or a milk-based formula to a formula with only trace levels of galactose or lactose, such as soy formula. Of note, some infants with classic galactosemia are prescribed elemental formula, which has even lower galactose content than soy formula. Elemental formula should not be prescribed for infants with generalized epimerase deficiency galactosemia because the GALE enzyme is required for the endogenous biosynthesis of UDP-galactose; that is, <b>persons with epimerase deficiency galactosemia may require trace environmental sources of galactose</b>. However, the galactose intake needed for optimum outcome remains unknown.</p><p>For older children with generalized epimerase deficiency galactosemia, dietary restriction of galactose/lactose involves continued restriction of dairy products.</p><p>Note: Some, but not all, physicians recommend that individuals with classic galactosemia also abstain from non-dairy foods that contain more than trace levels of galactose/lactose (e.g., some fruits and vegetables, organ meats); this more rigorous dietary restriction may not be advisable for persons with generalized epimerase deficiency galactosemia.</p><p>In generalized epimerase deficiency galactosemia restriction of dietary galactose/lactose appears to correct or prevent the acute signs and symptoms of the disorder: hepatic dysfunction, renal dysfunction, and mild cataracts. Presumably, as in classic galactosemia, dietary treatment would not correct profound tissue damage resulting from prolonged galactose exposure (e.g., hepatic cirrhosis or mature cataracts). Mature cataracts that do not resolve with dietary restriction of galactose/lactose may require surgical removal.</p></div><div id="gale-def.Peripheral_Epimerase_Deficiency_1"><h4>Peripheral Epimerase Deficiency Galactosemia</h4><p>Individuals with peripheral epimerase deficiency galactosemia do not require any dietary restriction.</p></div><div id="gale-def.Intermediate_Epimerase_Deficien_1"><h4>Intermediate Epimerase Deficiency Galactosemia</h4><p>Individuals with intermediate epimerase deficiency galactosemia are typically treated with dietary galactose/lactose restriction, at least in infancy. They may be an (as-yet unknown) increased risk for long-term complications including learning impairment and/or cataracts. Continued breastfeeding or exposure to a milk-based formula containing high levels of galactose/lactose may therefore be inadvisable for these infants; however, insufficient data exist to make firm recommendations.</p></div></div><div id="gale-def.Prevention_of_Primary_Manifesta"><h3>Prevention of Primary Manifestations</h3><p>In generalized epimerase deficiency galactosemia dietary restriction of galactose/lactose prevents early feeding problems, vomiting, poor weight gain, hepatic dysfunction, and cataracts.</p><p>The challenge in treating an asymptomatic newborn with epimerase deficiency galactosemia is that it may take months to obtain the results of tests used to distinguish peripheral epimerase deficiency galactosemia from intermediate epimerase deficiency galactosemia (see Establishing the Diagnosis, <a href="#gale-def.Additional_Testing">Additional Testing</a>); furthermore, such tests may not be available. The most conservative approach, therefore, is to advise dietary restriction of galactose/lactose for all infants with epimerase deficiency galactosemia, relaxing the restriction as warranted once a more accurate diagnosis has been confirmed.</p></div><div id="gale-def.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Monitor hemolysate gal-1P or urinary galactitol, especially if the diet is to be normalized. Acceptable levels of gal-1P in GALE deficiency are not known but are estimated from experience with classic galactosemia to be &#x0003c;3.5 mg/100 mL in red blood cells.</div></li><li class="half_rhythm"><div>Follow growth.</div></li><li class="half_rhythm"><div>Monitor developmental milestones; propose supportive intervention as needed.</div></li></ul></div><div id="gale-def.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Persons with generalized epimerase deficiency galactosemia should be on a galactose/lactose-restricted diet, certainly as infants and perhaps for life.</p><p>Persons with intermediate epimerase deficiency galactosemia may be placed on a galactose/lactose-restricted diet, either transiently or long-term. Assessment of hemolysate gal-1P and/or urinary galactitol following a galactose challenge (e.g., 2 weeks on a normal diet) may help determine if an individual should remain on a galactose/lactose-restricted diet for longer periods of time.</p></div><div id="gale-def.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If prenatal testing has not been performed (see <a href="#gale-def.Genetic_Counseling">Genetic Counseling</a>), each at-risk newborn sib should be treated from birth until results of diagnostic testing are available. Diagnostic evaluations can include:</p><ul><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div class="half_rhythm">Measurement of GALE enzyme activity in red blood cells if the pathogenic variants in the family are not known.</div><div class="half_rhythm">Note: If there are concerns about the reliability of the prenatal testing, soy-based formula may be given while the diagnostic testing is being performed.</div></li></ul><p>See <a href="#gale-def.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gale-def.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="gale-def.Genetic_Counseling"><h2 id="_gale-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gale-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Epimerase deficiency galactosemia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="gale-def.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically heterozygotes (i.e., carriers of a <i>GALE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing symptoms of generalized epimerase deficiency galactosemia.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each full sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and also not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing symptoms of generalized epimerase deficiency galactosemia.</div></li><li class="half_rhythm"><div>Data [<a class="bk_pop" href="#gale-def.REF.walter.1999.374">Walter et al 1999</a>] suggest that the subtype of epimerase deficiency galactosemia identified in a given family should &#x0201c;run true,&#x0201d; meaning that if one sib has generalized epimerase deficiency galactosemia, other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs in that family are likely to have generalized epimerase deficiency galactosemia; if one sib has peripheral epimerase deficiency galactosemia, other sibs in that family are likely to have the same form.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> All of the offspring conceived by an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with an unaffected, non-<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> partner are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GALE</i>.</p><p><b>Other family members.</b> Assuming no other family history of galactosemia, each full sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GALE</i>.</p></div><div id="gale-def.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> requires prior identification of the <i>GALE</i> pathogenic variants in the family.</p><p>Although biochemical testing to detect carriers is also a possibility, the ranges for control and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> GALE enzyme activity overlap, thus making <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> the preferred method for carrier detection.</p><p>Note: Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder and are not at risk of developing symptoms of generalized epimerase deficiency galactosemia.</p></div><div id="gale-def.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#gale-def.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at increased risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gale-def.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>GALE</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for epimerase deficiency galactosemia are possible.</p></div></div><div id="gale-def.Resources"><h2 id="_gale-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>The Galactosemia Foundation</b></div><div>P.O. Box 2401</div><div>Mandeville LA 70471</div><div><b>Phone:</b> 866-900-7421</div><div><b>Email:</b> president@galactosemia.org</div><div><a href="http://galactosemia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">galactosemia.org</a></div></li><li class="half_rhythm"><div><b>Association for Neuro-Metabolic Disorders (ANMD)</b></div><div>5223 Brookfield Lane</div><div>Sylvania OH 43560-1809</div><div><b>Phone:</b> 419-885-1809; 419-885-1497</div><div><b>Email:</b> volk4olks@aol.com</div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="gale-def.Molecular_Genetics"><h2 id="_gale-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gale-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Epimerase Deficiency Galactosemia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK51671/table/gale-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gale-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gale-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gale-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gale-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gale-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gale-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gale-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gale-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GALE</i></a></td><td headers="hd_b_gale-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_gale-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14376" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UDP-glucose 4-epimerase</a></td><td headers="hd_b_gale-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GALE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GALE database</a></td><td headers="hd_b_gale-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GALE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GALE</a></td><td headers="hd_b_gale-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GALE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GALE</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gale-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gale-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Epimerase Deficiency Galactosemia (<a href="/omim/230350,606953" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK51671/table/gale-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gale-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/230350" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">230350</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GALACTOSE EPIMERASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606953" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606953</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UDP-GALACTOSE-4-EPIMERASE; GALE</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>GALE</i> is just over 4 kb in length and has 11 coding exons that together encode a protein of 348 amino acids. Multiple alternatively spliced transcripts encoding the same protein have been identified. Transcript <a href="/nuccore/NM_000403.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_000403.3</u></a> represents the longest transcript with 1647 nucleotides and 12 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK51671/#gale-def.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> For the purposes of this review, variants are considered pathogenic if they have been shown to reduce GALE expression, stability, or catalytic function in any cell type or assay system, whether or not they are known to cause clinical features. Most individuals identified with epimerase deficiency galactosemia are clinically asymptomatic, but do have <i>GALE</i> sequence variants that explain, or may explain, their biochemical findings.</p><p>One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.280G&#x0003e;A, has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state in persons with the severe, generalized form of epimerase deficiency galactosemia [<a class="bk_pop" href="#gale-def.REF.wohlers.1999.462">Wohlers et al 1999</a>]. This pathogenic variant leaves approximately 5% residual enzyme activity with regard to UDP-gal metabolism and close to 25% residual enzyme activity with regard to UDP-galNAc metabolism [<a class="bk_pop" href="#gale-def.REF.wohlers.1999.462">Wohlers et al 1999</a>, <a class="bk_pop" href="#gale-def.REF.wohlers.2000.713">Wohlers &#x00026; Fridovich-Keil 2000</a>].</p><p>Other pathogenic variants have been shown to cause moderate to severe reduction in GALE enzyme activity in vitro or in model systems (e.g., c.269G&#x0003e;A or c.548T&#x0003e;C [<a class="bk_pop" href="#gale-def.REF.quimby.1997.590">Quimby et al 1997</a>, <a class="bk_pop" href="#gale-def.REF.wohlers.1999.462">Wohlers et al 1999</a>, <a class="bk_pop" href="#gale-def.REF.timson.2005.6170">Timson 2005</a>]), but to date these alleles have been identified only in persons who are heterozygotes or compound heterozygotes.</p><p>The in vivo consequence of homozygosity for apparently severe pathogenic variants other than c.280G&#x0003e;A is unknown. Of note, no individuals reported with GALE enzyme deficiency have been completely <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> for GALE enzyme activity in non-peripheral cells: biochemical reasoning [<a class="bk_pop" href="#gale-def.REF.kalckar.1965.305">Kalckar 1965</a>] as well as fruit fly [<a class="bk_pop" href="#gale-def.REF.sanders.2010.628">Sanders et al 2010</a>, <a class="bk_pop" href="#gale-def.REF.daenzer.2012.e1002721">Daenzer et al 2012</a>] and <i>C elegans</i> [<a class="bk_pop" href="#gale-def.REF.brokatellanos.2014.1559">Brokate-Llanos et al 2014</a>] models for GALE impairment suggest that complete loss of GALE enzyme activity may be incompatible with life for humans and other metazoans.</p><p>The potential for interaction between two <i>GALE</i> alleles must also be considered. For example, a partial <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect has been described in a yeast model system for the c.548T&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, which demonstrates low GALE enzyme activity, and the c.101A&#x0003e;G pathogenic variant, which demonstrates slightly reduced GALE enzyme activity when expressed alone [<a class="bk_pop" href="#gale-def.REF.quimby.1997.590">Quimby et al 1997</a>].</p><p><i>GALE</i> variant alleles that are common in specific populations include the following:</p><ul><li class="half_rhythm"><div>The c.505C&#x0003e;T, c.715C&#x0003e;T, and c.905G&#x0003e;A pathogenic variants together account for 67% of alleles reported in a cohort of asymptomatic Koreans with peripheral epimerase deficiency galactosemia [<a class="bk_pop" href="#gale-def.REF.park.2005.646">Park et al 2005</a>].</div></li><li class="half_rhythm"><div>The c.770A&#x0003e;G and c.956G&#x0003e;A pathogenic variants are associated with asymptomatic peripheral epimerase deficiency galactosemia in African Americans [<a class="bk_pop" href="#gale-def.REF.alano.1997.191a">Alano et al 1997</a>, <a class="bk_pop" href="#gale-def.REF.fridovichkeil.2008">Fridovich-Keil &#x00026; Walter 2008</a>].</div></li></ul><div id="gale-def.T.selected_gale_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>GALE</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK51671/table/gale-def.T.selected_gale_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gale-def.T.selected_gale_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gale-def.T.selected_gale_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_gale-def.T.selected_gale_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Peripheral</b></td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.505C&#x0003e;T</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg169Trp</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_4" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000403.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_000403.3</u></a><br /><a href="/protein/NP_000394.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_000394.2</u></a></td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.715C&#x0003e;T</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg239Trp</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.770A&#x0003e;G</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys257Arg</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.905G&#x0003e;A</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly302Asp</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.956G&#x0003e;A</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly319Glu</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Suspected intermediate</b></td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.101A&#x0003e;G</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn34Ser&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Reported or suspected generalized</b></td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.269G&#x0003e;A</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly90Glu</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.280G&#x0003e;A</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val94Met</td></tr><tr><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.548T&#x0003e;C</td><td headers="hd_h_gale-def.T.selected_gale_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu183Pro&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="gale-def.TF.2.1"><p class="no_margin">Observed in <a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a> in an individual with intermediate GALE deficiency; however, expression studies in a yeast model system demonstrated that p.Leu183Pro causes profound loss of GALE activity. The individual in whom this <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> was identified may have had intermediate GALE deficiency because the other allele was mild (p.Asn34Ser). Evidence for a potential <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect between p.Asn34Ser and p.Leu183Pro has also been reported.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>. The UDP-galactose 4'-epimerase (known in UniProt as UDP-glucose 4-epimerase) protein encoded by <i>GALE</i> has 348 amino acids.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Deficient GALE activity, either generalized or peripherial, causes epimerase deficiency galactosemia.</p></div><div id="gale-def.References"><h2 id="_gale-def_References_">References</h2><div id="gale-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.alano.1998.341">Alano A, Almashanu S, Chinsky JM, Costeas P, Blitzer MG, Wulfsberg EA, Cowan TM. Molecular characterization of a unique patient with epimerase-deficiency galactosaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1998;<span class="ref-vol">21</span>:341–50.</span> [<a href="/pubmed/9700591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9700591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.alano.1997.191a">Alano A, Almashanu S, Maceratesi P, Reichardt J, Panny S, Cowan TM. UDP-galactose-4-epimerase deficiency among African-Americans: evidence for multiple alleles. <span><span class="ref-journal">J Invest Med. </span>1997;<span class="ref-vol">45</span>:191A.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.brokatellanos.2014.1559">Brokate-Llanos AM, Monje JM, Murdoch Pdel S, Mu&#x000f1;oz MJ. Developmental defects in a Caenorhabditis elegans model for type III galactosemia. <span><span class="ref-journal">Genetics. </span>2014;<span class="ref-vol">198</span>:1559–69.</span> [<a href="/pmc/articles/PMC4256771/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4256771</span></a>] [<a href="/pubmed/25298520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25298520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.chen.2014.5">Chen J, Meyers GA, Bennett MJ. An interference-free two-step enzyme assay with UPLC-tandem mass spectrometric product measurement for the clinical diagnosis of uridine diphosphate galactose-4-epimerase deficiency. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2014;2014;<span class="ref-vol">959</span>:5–9.</span> [<a href="/pubmed/24732214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24732214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.daenzer.2012.e1002721">Daenzer JM, Sanders RD, Hang D, Fridovich-Keil JL. UDP-galactose 4'-epimerase activities toward UDP-Gal and UDP-GalNAc play different roles in the development of Drosophila melanogaster. <span><span class="ref-journal">PLoS Genet. </span>2012;<span class="ref-vol">8</span>:e1002721.</span> [<a href="/pmc/articles/PMC3359975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3359975</span></a>] [<a href="/pubmed/22654673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22654673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.fridovichkeil.2008">Fridovich-Keil JL, Walter JH. Galactosemia. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A, eds. <em>The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</em> Chap 72. McGraw-Hill. 2008.</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.gitzelmann.1972.125">Gitzelmann R. Deficiency of uridine diphosphate galactose 4-epimerase in blood cells of an apparently healthy infant. Preliminary communication. <span><span class="ref-journal">Helv Paediatr Acta. </span>1972;<span class="ref-vol">27</span>:125–30.</span> [<a href="/pubmed/4644860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4644860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.henderson.1983.17">Henderson MJ, Holton JB, MacFaul R. Further observations in a case of uridine diphosphate galactose-4-epimerase deficiency with a severe clinical presentation. <span><span class="ref-journal">J Inherit Metab Dis. </span>1983;<span class="ref-vol">6</span>:17–20.</span> [<a href="/pubmed/6408303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6408303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.hennermann.2011.399">Hennermann JB, Schadewaldt P, Vetter B, Shin YS, M&#x000f6;nch E, Klein J. Features and outcome of galactokinase deficiency in children diagnosed by newborn screening. <span><span class="ref-journal">J Inherit Metab Dis. </span>2011;<span class="ref-vol">34</span>:399–407.</span> [<a href="/pubmed/21290184" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21290184</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.holton.1981.885">Holton JB, Gillett MG, MacFaul R, Young R. Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. <span><span class="ref-journal">Arch Dis Child. </span>1981;<span class="ref-vol">56</span>:885–7.</span> [<a href="/pmc/articles/PMC1627389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1627389</span></a>] [<a href="/pubmed/7305435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7305435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.hunter.2001.77">Hunter M, Angelicheva D, Levy HL, Pueschel SM, Kalaydjieva L. Novel mutations in the GALK1 gene in patients with galactokinase deficiency. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:77–8.</span> [<a href="/pubmed/11139256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11139256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.kalckar.1965.305">Kalckar HM. Galactose metabolism and cell "sociology". <span><span class="ref-journal">Science. </span>1965;<span class="ref-vol">150</span>:305–13.</span> [<a href="/pubmed/5319435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5319435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.kolosha.2000.447">Kolosha V, Anoia E, de Cespedes C, Gitzelmann R, Shih L, Casco T, Saborio M, Trejos R, Buist N, Tedesco T, Skach W, Mitelmann O, Ledee D, Huang K, Stambolian D. Novel mutations in 13 probands with galactokinase deficiency. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">15</span>:447–53.</span> [<a href="/pubmed/10790206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10790206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.mitchell.1975.5026">Mitchell B, Haigis E, Steinmann B, Gitzelmann R. Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1975;<span class="ref-vol">72</span>:5026–30.</span> [<a href="/pmc/articles/PMC388868/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC388868</span></a>] [<a href="/pubmed/1748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.openo.2006.89">Openo KK, Schulz JM, Vargas CA, Orton CS, Epstein MP, Schnur RE, Scaglia F, Berry GT, Gottesman GS, Ficicioglu C, Slonim AE, Schroer RJ, Yu C, Rangel VE, Keenan J, Lamance K, Fridovich-Keil JL. Epimerase-deficiency galactosemia is not a binary condition. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:89–102.</span> [<a href="/pmc/articles/PMC1380226/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1380226</span></a>] [<a href="/pubmed/16385452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16385452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.park.2005.646">Park HD, Park KU, Kim JQ, Shin CH, Yang SW, Lee DH, Song YH, Song J. The molecular basis of UDP-galactose-4-epimerase (GALE) deficiency galactosemia in Korean patients. <span><span class="ref-journal">Genet Med. </span>2005;<span class="ref-vol">7</span>:646–9.</span> [<a href="/pubmed/16301867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16301867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.quimby.1997.590">Quimby BB, Alano A, Almashanu S, DeSandro AM, Cowan TM, Fridovich-Keil JL. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:590–8.</span> [<a href="/pmc/articles/PMC1715948/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715948</span></a>] [<a href="/pubmed/9326324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.sanders.2010.628">Sanders RD, Sefton JM, Moberg KH, Fridovich-Keil JL. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster. <span><span class="ref-journal">Dis Model Mech. </span>2010;<span class="ref-vol">3</span>:628–38.</span> [<a href="/pmc/articles/PMC2931539/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2931539</span></a>] [<a href="/pubmed/20519568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20519568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.sarkar.2010.909">Sarkar M, Bose SS, Mondal G, Chatterjee S. Generalized epimerase deficiency galactosemia. <span><span class="ref-journal">Indian J Pediatr. </span>2010;<span class="ref-vol">77</span>:909–10.</span> [<a href="/pubmed/20725869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20725869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.tegtmeyer.2014.533">Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Lafor&#x000ea;t P, Petit F, Auma&#x000ee;tre O, Czarnowska E, Piraud M, Podskarbi T, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C, Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T. Multiple phenotypes in phosphoglucomutase 1 deficiency. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">370</span>:533–42.</span> [<a href="/pmc/articles/PMC4373661/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4373661</span></a>] [<a href="/pubmed/24499211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24499211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.timson.2005.6170">Timson DJ. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase. <span><span class="ref-journal">FEBS J. </span>2005;<span class="ref-vol">272</span>:6170–7.</span> [<a href="/pubmed/16302980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16302980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.walter.1999.374">Walter JH, Roberts RE, Besley GT, Wraith JE, Cleary MA, Holton JB, MacFaul R. Generalised uridine diphosphate galactose-4-epimerase deficiency. <span><span class="ref-journal">Arch Dis Child. </span>1999;<span class="ref-vol">80</span>:374–6.</span> [<a href="/pmc/articles/PMC1717903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1717903</span></a>] [<a href="/pubmed/10086948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10086948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.wohlers.1999.462">Wohlers TM, Christacos NC, Harreman MT, Fridovich-Keil JL. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:462–70.</span> [<a href="/pmc/articles/PMC1377755/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377755</span></a>] [<a href="/pubmed/9973283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gale-def.REF.wohlers.2000.713">Wohlers TM, Fridovich-Keil JL. Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span>:713–29.</span> [<a href="/pubmed/11117433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11117433</span></a>]</div></li></ul></div></div><div id="gale-def.Chapter_Notes"><h2 id="_gale-def_Chapter_Notes_">Chapter Notes</h2><div id="gale-def.Acknowledgments"><h3>Acknowledgments</h3><p>The authors gratefully acknowledge the time and efforts of the many patients, families, health care professionals, and scientists who have brought our knowledge of epimerase deficiency galactosemia to its current state. JLFK also gratefully acknowledges funding from the National Institutes of Health and the Galactosemia Foundation.</p></div><div id="gale-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>16 June 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 October 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 January 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>31 August 2010 (jfk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK51671</span><span class="label">PMID: <a href="/pubmed/21290786" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21290786</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/eb-pa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ea1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK51671&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK51671/?report=reader">PubReader</a></li><li><a href="/books/NBK51671/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK51671" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK51671" style="display:none" title="Cite this Page"><div class="bk_tt">Fridovich-Keil J, Bean L, He M, et al. Epimerase Deficiency Galactosemia. 2011 Jan 25 [Updated 2016 Jun 16]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK51671/pdf/Bookshelf_NBK51671.pdf">PDF version of this page</a> (452K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gale-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gale-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gale-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gale-def.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#gale-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gale-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gale-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gale-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gale-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gale-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gale-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2582[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GALE</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK51671+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2397410" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2397410" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2397410" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2397410" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301691" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Berry GT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16385452" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Epimerase-deficiency galactosemia is not a binary condition.</a><span class="source">[Am J Hum Genet. 2006]</span><div class="brieflinkpop offscreen_noflow">Epimerase-deficiency galactosemia is not a binary condition.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Openo KK, Schulz JM, Vargas CA, Orton CS, Epstein MP, Schnur RE, Scaglia F, Berry GT, Gottesman GS, Ficicioglu C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2006 Jan; 78(1):89-102. Epub 2005 Nov 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25473725" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Duarte Variant Galactosemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Duarte Variant Galactosemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fridovich-Keil JL, Gambello MJ, Singh RH, Sharer JD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23430501" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Case Study of Monozygotic Twins Apparently Homozygous for a Novel Variant of UDP-Galactose 4'-epimerase (GALE) : A Complex Case of Variant GALE.</a><span class="source">[JIMD Rep. 2013]</span><div class="brieflinkpop offscreen_noflow">A Case Study of Monozygotic Twins Apparently Homozygous for a Novel Variant of UDP-Galactose 4'-epimerase (GALE) : A Complex Case of Variant GALE.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu Y, Bentler K, Coffee B, Chhay JS, Sarafoglou K, Fridovich-Keil JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">JIMD Rep. 2013; 7:89-98. Epub 2012 Jul 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21290786" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21290786" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8f5c39a66ee2ba96b649">Epimerase Deficiency Galactosemia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Epimerase Deficiency Galactosemia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:07:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88821EDFC890F10000000003070177&amp;ncbi_session=CE88821EDFC8F5C1_0775SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK51671%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK51671&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK51671/&amp;ncbi_pagename=Epimerase Deficiency Galactosemia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88821EDFC8F5C1_0775SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>